| Name | Title | Contact Details |
|---|---|---|
Beverly Gates |
Vice President, General Counsel and Secretary, Simplot Grower Solutions | Profile |
We’re committed to making the world a healthier place with solutions for the nutrition, food, sterilization, and energy markets.
FarmLogix, LLC uses customized technology (patent pending) to connect local farms with a variety of outlets, including schools, institutions, restaurants, and hotels, as well as individual homes through CSA`s. FarmLogix lifts hurdles in sourcing, reporting, logistical, and demographic and economics, and allows for easier access to locally-grown food across America.
PIM Brands, Inc. (PIM) is one of North America`s premier makers of fruit snacks, confections and other treats. PIM is ranked amongst the top 50 global confectionery companies and has also been named as one of the fastest growing CPG companies in the U.S. by Boston Consulting Group and IRI four times in the past six years.
Neptune is a biotechnology company engaged primarily in the development and commercialization of marine-derived omega-3 polyunsaturated fatty acids ("PUFAs"). Neptune has a patented process of extracting oils from Antarctic krill, and principally sells omega-3 PUFAs as bulk oil to Neptune`s distributors who commercialize them under their private label primarily in the U.S., European and Australian nutraceutical markets. Neptune`s products generally come in bulk oil or capsule form and serve as a dietary supplement to consumers. Neptune`s head office is located at 545 Promenade du Centropolis, Suite 100, Laval, Quebec. Neptune respectively holds approximately 49% of the participating and voting rights of Acasti and 96% of the voting rights of NeuroBio. Through these subsidiaries, Neptune is also pursuing opportunities in the medical food and prescription drug markets. Acasti and NeuroBio respectively focus on the research and development of safe and therapeutically effective compounds for highly prevalent atherosclerotic conditions, such as cardiometabolic disorders and cardiovascular diseases, and for neurodegenerative and inflammation related conditions. Acasti`s lead prescription drug candidate is CaPre(R), a purified high omega-3 phospholipid concentrate derived from Neptune krill oil being developed to address the prevention and treatment of cardiometabolic disorders, including hypertriglyceridemia, which is characterized by abnormally high levels of triglycerides.